Your browser doesn't support javascript.
loading
Bacterial genotypic and patient risk factors for adverse outcomes in Escherichia coli bloodstream infections: a prospective molecular epidemiological study.
Jauneikaite, Elita; Honeyford, Kate; Blandy, Oliver; Mosavie, Mia; Pearson, Max; Ramzan, Farzan A; Ellington, Matthew J; Parkhill, Julian; Costelloe, Céire E; Woodford, Neil; Sriskandan, Shiranee.
Afiliación
  • Jauneikaite E; NIHR Health Protection Research Unit for Healthcare Associated Infections and Antimicrobial Resistance, Department of Infectious Disease, Imperial College London, London, UK.
  • Honeyford K; Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, UK.
  • Blandy O; NIHR Health Protection Research Unit for Healthcare Associated Infections and Antimicrobial Resistance, Department of Infectious Disease, Imperial College London, London, UK.
  • Mosavie M; Global Digital Health Unit, Department of Primary Care and Public Health, School of Public Health, Imperial College London, London, UK.
  • Pearson M; NIHR Health Protection Research Unit for Healthcare Associated Infections and Antimicrobial Resistance, Department of Infectious Disease, Imperial College London, London, UK.
  • Ramzan FA; NIHR Health Protection Research Unit for Healthcare Associated Infections and Antimicrobial Resistance, Department of Infectious Disease, Imperial College London, London, UK.
  • Ellington MJ; NIHR Health Protection Research Unit for Healthcare Associated Infections and Antimicrobial Resistance, Department of Infectious Disease, Imperial College London, London, UK.
  • Parkhill J; NIHR Health Protection Research Unit for Healthcare Associated Infections and Antimicrobial Resistance, Department of Infectious Disease, Imperial College London, London, UK.
  • Costelloe CE; NIHR Health Protection Research Unit for Healthcare Associated Infections and Antimicrobial Resistance, Department of Infectious Disease, Imperial College London, London, UK.
  • Woodford N; National Infection Service Laboratories, National Infection Service, UK Health Security Agency (formerly Public Health England), UK.
  • Sriskandan S; Wellcome Sanger Institute, Hinxton, Cambridge, UK.
J Antimicrob Chemother ; 77(6): 1753-1761, 2022 05 29.
Article en En | MEDLINE | ID: mdl-35265995
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Bacteriemia / Infecciones por Escherichia coli / Antiinfecciosos Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Antimicrob Chemother Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Bacteriemia / Infecciones por Escherichia coli / Antiinfecciosos Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Antimicrob Chemother Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido